BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2014 12:31:00 PM | Browse: 1487 | Download: 1867
 |
Received |
|
2014-06-04 08:03 |
 |
Peer-Review Started |
|
2014-06-04 22:02 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-07-07 10:03 |
 |
Revised |
|
2014-07-22 03:37 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-09-01 15:16 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-09-01 15:21 |
 |
Articles in Press |
|
2014-09-01 15:22 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-15 12:56 |
 |
Publish the Manuscript Online |
|
2014-09-25 12:31 |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Minireviews |
| Article Title |
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christen L Walters Haygood, Rebecca C Arend, J Michael Straughn and Donald J Buchsbaum |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christen L Walters Haygood, MD, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 1700 6th Ave South, WIC 10250, Birmingham, AL 35233, United States. cwalters@uabmc.edu |
| Key Words |
Epithelial ovarian cancer; Cancer stem cells; Chemoresistance; Targeted therapy; Chemotherapy; Recurrent ovarian cancer |
| Core Tip |
Ovarian cancer stem cells (CSCs) are difficult to isolate, identify, and target. However, they are often thought to be the source of development of chemoresistance. Finding a therapeutic target in ovarian CSCs and identifying the mechanisms associated with the development of chemoresistance may lead to a long-lasting cure for patients with epithelial ovarian cancer. |
| Publish Date |
2014-09-25 12:31 |
| Citation |
Walters Haygood CL, Arend RC, Straughn JM, Buchsbaum DJ. Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival? World J Stem Cells 2014; 6(4): 441-447 |
| URL |
http://www.wjgnet.com/1948-0210/full/v6/i4/441.htm |
| DOI |
http://dx.doi.org/10.4252/wjsc.v6.i4.441 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.